Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-01

Clinical Trial Update: Development of Pregnenolone as a Treatment for Depression [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating pregnenolone for major depressive disorder has been completed and results were posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregnenolone (pregnenolone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2024-05-01